Henry Schein, Inc.
HSICHealthcareNASDAQMedical Distribution
Scan Results
Daily timeframeHenry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. The $9.93B market capitalization puts HSIC squarely in mid-cap range for its industry. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
Market Cap
$9.93B
Beta
0.81
P/E (TTM)
26.25
P/E (Fwd)
14.75
EPS (TTM)
$3.32
EPS (Fwd)
$5.91
ROE
8.8%
ROA
4.4%
Cash
$138.0M
Total Debt
$3.75B
Free CF
$290.1M
52W Change
25.7%
Annual Financials
Cash vs Debt
Henry Schein, Inc. carries $3.75B in total debt against $138.0M in cash reserves — debt is roughly 27.2x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $290.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 8.8%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.4% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $12.65B (2022) to $13.18B (2025).
Henry Schein, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing HSIC.